Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Increased bronchoalveolar lavage human beta-defensin type 2 in bronchiolitis obliterans syndrome after lung transplantation.

Ross DJ, Cole AM, Yoshioka D, Park AK, Belperio JA, Laks H, Strieter RM, Lynch JP 3rd, Kubak B, Ardehali A, Ganz T.

Transplantation. 2004 Oct 27;78(8):1222-4.

PMID:
15502724
3.

Airway neutrophilia in stable and bronchiolitis obliterans syndrome patients following lung transplantation.

Zheng L, Walters EH, Ward C, Wang N, Orsida B, Whitford H, Williams TJ, Kotsimbos T, Snell GI.

Thorax. 2000 Jan;55(1):53-9.

4.
5.

Longitudinal comparisons of lymphocytes and subtypes between airway wall and bronchoalveolar lavage after human lung transplantation.

Zheng L, Orsida B, Whitford H, Levvey B, Ward C, Walters EH, Williams TJ, Snell GI.

Transplantation. 2005 Jul 27;80(2):185-92.

PMID:
16041262
6.

Increased concentrations of human beta-defensins in plasma and bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis.

Hiratsuka T, Mukae H, Iiboshi H, Ashitani J, Nabeshima K, Minematsu T, Chino N, Ihi T, Kohno S, Nakazato M.

Thorax. 2003 May;58(5):425-30.

7.

Antimicrobial peptides in lung transplant recipients with bronchiolitis obliterans syndrome.

Anderson RL, Hiemstra PS, Ward C, Forrest IA, Murphy D, Proud D, Lordan J, Corris PA, Fisher AJ.

Eur Respir J. 2008 Sep;32(3):670-7. doi: 10.1183/09031936.00110807. Epub 2008 May 28.

8.

Effect of inhaled fluticasone propionate on BAL TGF-beta(1) and bFGF concentrations in clinically stable lung transplant recipients.

Zheng L, Walters EH, Wang N, Whitford H, Orsida B, Levvey B, Bailey M, Williams TJ, Snell GI.

J Heart Lung Transplant. 2004 Apr;23(4):446-55.

PMID:
15063404
9.

Role of defensins in the pathogenesis of chronic lung allograft rejection.

Tiriveedhi V, Banan B, Deepti S, Nataraju A, Hachem R, Trulock E, Alexander PG, Thalachallour M.

Hum Immunol. 2014 Apr;75(4):370-7. doi: 10.1016/j.humimm.2013.12.014. Epub 2013 Dec 28.

10.

C-reactive protein in bronchoalveolar lavage fluid is associated with markers of airway inflammation after lung transplantation.

Vos R, Vanaudenaerde BM, De Vleeschauwer SI, Willems-Widyastuti A, Dupont LJ, Van Raemdonck DE, Verleden GM.

Transplant Proc. 2009 Oct;41(8):3409-13. doi: 10.1016/j.transproceed.2009.09.029.

PMID:
19857759
11.

Upregulation of chemokines in bronchoalveolar lavage fluid as a predictive marker of post-transplant airway obliteration.

Reynaud-Gaubert M, Marin V, Thirion X, Farnarier C, Thomas P, Badier M, Bongrand P, Giudicelli R, Fuentes P.

J Heart Lung Transplant. 2002 Jul;21(7):721-30.

PMID:
12100898
12.

Synergistic effect of antibodies to human leukocyte antigens and defensins in pathogenesis of bronchiolitis obliterans syndrome after human lung transplantation.

Saini D, Angaswamy N, Tiriveedhi V, Fukami N, Ramachandran S, Hachem R, Trulock E, Meyers B, Patterson A, Mohanakumar T.

J Heart Lung Transplant. 2010 Dec;29(12):1330-6. doi: 10.1016/j.healun.2010.05.036. Epub 2010 Aug 5.

13.

Airway vascular changes after lung transplant: potential contribution to the pathophysiology of bronchiolitis obliterans syndrome.

Langenbach SY, Zheng L, McWilliams T, Levvey B, Orsida B, Bailey M, Williams TJ, Snell GI.

J Heart Lung Transplant. 2005 Oct;24(10):1550-6.

PMID:
16210129
14.

The role of the IL23/IL17 axis in bronchiolitis obliterans syndrome after lung transplantation.

Vanaudenaerde BM, De Vleeschauwer SI, Vos R, Meyts I, Bullens DM, Reynders V, Wuyts WA, Van Raemdonck DE, Dupont LJ, Verleden GM.

Am J Transplant. 2008 Sep;8(9):1911-20. doi: 10.1111/j.1600-6143.2008.02321.x.

15.

Lung allograft dysfunction correlates with gamma-interferon gene expression in bronchoalveolar lavage.

Ross DJ, Moudgil A, Bagga A, Toyoda M, Marchevsky AM, Kass RM, Jordan SC.

J Heart Lung Transplant. 1999 Jul;18(7):627-36.

PMID:
10452338
16.

Interleukin-1 receptor antagonist as a biomarker for bronchiolitis obliterans syndrome in lung transplant recipients.

Belperio JA, DiGiovine B, Keane MP, Burdick MD, Ying Xue Y, Ross DJ, Lynch JP 3rd, Kunkel SL, Strieter RM.

Transplantation. 2002 Feb 27;73(4):591-9.

PMID:
11889437
17.

Bronchoalveolar lavage cytokine profile in a cohort of lung transplant recipients: a predictive role of interleukin-12 with respect to onset of bronchiolitis obliterans syndrome.

Meloni F, Vitulo P, Cascina A, Oggionni T, Bulgheroni A, Paschetto E, Klersy C, D'Armini AM, Fietta A, Bianco AM, Arbustini E, Viganò M.

J Heart Lung Transplant. 2004 Sep;23(9):1053-60.

PMID:
15454171
18.

Comparison of induced sputum and bronchoalveolar lavage in lung transplant recipients.

Mamessier E, Milhe F, Badier M, Thomas P, Magnan A, Reynaud-Gaubert M.

J Heart Lung Transplant. 2006 May;25(5):523-32. Epub 2006 Apr 11.

PMID:
16678030
19.

Bronchoalveolar lavage fluid characteristics in acute and chronic lung transplant rejection.

Slebos DJ, Postma DS, Koëter GH, Van Der Bij W, Boezen M, Kauffman HF.

J Heart Lung Transplant. 2004 May;23(5):532-40.

PMID:
15135367
20.

Clinical utility of bronchoalveolar lavage cell phenotype analyses in the postoperative monitoring of lung transplant recipients.

Reynaud-Gaubert M, Thomas P, Gregoire R, Badier M, Cau P, Sampol J, Giudicelli R, Fuentes P.

Eur J Cardiothorac Surg. 2002 Jan;21(1):60-6.

PMID:
11788258

Supplemental Content

Support Center